Babies are often overlooked as victims of the American opioid crisis, but anyone who works in a neonatal unit can recognize the high-pitched cries of a suffering newborn. Babies exposed to opioids in utero develop a dependency and suffer from withdrawal following birth. Known as Neonatal Abstinence Syndrome (NAS), fetal exposure to opioids can have short and long-term effects on the health and development of children. In many cases, babies are exposed to opioids after mothers sought legitimate relief from severe pain, were prescribed opioid painkillers, and became addicted.
Medical research into Neonatal Abstinence Syndrome shows opioid-addicted babies may suffer from withdrawal symptoms for the first several months of life. Well into their childhood years, developmental delays are also common and require intensive therapy. Critics say pharmaceutical executives were cognizant of the addiction risk associated with opioids yet intentionally misled consumers to believe the drugs were safe for long-term use. Retail sales of opioids reached a record $8 billion in 2014.
It seems unthinkable that pharmaceutical companies would knowingly downplay such serious risks to children to maximize profit, but such betrayals of consumer trust are all too common. Filing an opioid lawsuit may be the only means consumers have to hold big pharma accountable. Parents of opioid-addicted babies are filing lawsuits against opioid manufacturers to recover compensation for the suffering, harm, and medical expenses associated with infant opioid addiction. Opioid attorneys believe parents with babies born with NAS may be eligible for significant compensation through filing opioid lawsuits against manufacturers.
Many of the perils of opioid addiction are now well-known, but the effects of fetal opioid dependence are just beginning to be understood. When a fetus is exposed to opioids, they suffer from withdrawal at birth. Symptoms of opioid withdrawal in newborns include vomiting, seizures, diarrhea, and excessive crying. In the long term, opioid-addicted babies tend to struggle with growth and fail to meet developmental milestones, requiring intensive therapies throughout childhood. Families of opioid-addicted newborns may be eligible for compensation through filing an opioid lawsuit. Read full information on opioid-addicted newborns.
Neonatal Abstinence Syndrome is the medical term for the side effects of fetal opioid exposure. A baby exposed to opioid drugs in utero suffers from withdrawal symptoms shortly after birth. It is difficult to soothe babies experiencing opioid withdrawal; Neonatal Abstinence Syndrome can be detected through the presence of an eerily high-pitched and persistent cry. Neonatal Abstinence Syndrome also has long-term effects that hinder the healthy development and growth of the child. Families of babies born with Neonatal Abstinence Syndrome may be eligible for compensation through filing an opioid lawsuit. Read full information on Neonatal Abstinence Syndrome.
Parents of babies born with opioid dependence due to in-utero exposure are eligible for free, no-obligation case reviews with an attorney handling national opioid lawsuits for neonatal abstinence syndrome or NAS. Persons who match this description may be entitled to compensation through filing opioid lawsuits against pharmaceutical manufacturers. Lawyers handling opioid lawsuits work on a contingency basis, meaning we charge no legal fees unless we win compensation for you. Read full opioid lawsuit information from lawyers handling claims from plaintiffs nationwide.
This page contains answers to frequently asked questions on filing an opioid lawsuit for an opioid-dependent newborn. The answers, compiled by attorneys handling national opioid lawsuit claims, will apply to most general questions. If you have further questions or would prefer to speak with an attorney handling opioid lawsuit claims for babies diagnosed with Neonatal Abstinence Syndrome, contact our firm for a free, no-obligation case review. Read full opioid lawsuit questions and answers.
Our opioid lawyers have a long track record of winning cases on behalf of American families harmed by multinational pharmaceuticals. Anytime a billion-dollar pharmaceutical compromises consumer safety to maximize profit, our opioid attorneys see it as our mission to pursue justice no matter how complex the case. When the most vulnerable among us, newborns, are at the center of the scandal, our opioid lawyers double down on their commitment. Our opioid-addicted infants attorneys can help your family to recover needed compensation for medical expenses, suffering, and harm suffered by your child due to the negligence and greed of wealthy industry executives. Read full information from opioid lawyers on filing a lawsuit on behalf of an opioid-addicted newborn. Contact us to learn more.